Skip to main content
DaehanPharmaceutical logo

DaehanPharmaceutical — Investor Relations & Filings

Ticker · 023910 ISIN · KR7023910003 KO Manufacturing
Open in API
Filings indexed 297 across all filing types
Latest filing 2022-09-02 Major Shareholding Noti…
Country KR South Korea
Listing KO 023910

About DaehanPharmaceutical

https://www.dhnp.co.kr/

Daehan Nupharm is a pharmaceutical company engaged in the research, development, and manufacturing of a diverse portfolio of healthcare products. The company's business is structured around four core areas: human pharmaceuticals, offering a range of therapeutic treatments; animal health products for both companion and livestock animals; advanced bio-pharmaceuticals, with a focus on next-generation technologies like cell therapy; and health functional foods. Established initially in the animal health sector, the company leverages its dedicated Central and Bio Research Institutes to drive innovation and develop solutions for global markets. The R&D efforts concentrate on strengthening technological capabilities and advancing new treatment modalities.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 1% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed by Mirae Asset Global Investments regarding their stake in Daehan Pharmaceutical Co., Ltd. This type of filing is a standard regulatory requirement in South Korea for entities that cross a 5% ownership threshold or experience significant changes in their holdings. It details the number of shares held, the purpose of the investment (simple investment), and a chronological list of transactions. This falls under the category of 'Major Shareholding Notification'.
2022-09-02 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Financial Supervisory Service and Korea Exchange. It details share transactions (purchases) made by an executive (Lee Seung-young) of Daehan Pharmaceutical Co., Ltd. This type of filing is specifically categorized as 'Director's Dealing' (DIRS) as it reports insider trading activities by company management.
2022-08-30 Korean
반기보고서 (2022.06)
Interim / Quarterly Report Classification · 1% confidence The document is a 'Semi-Annual Report' (반기보고서) for the period 2022-01-01 to 2022-06-30, submitted to the Financial Services Commission and Korea Exchange. It contains detailed financial statements, management discussion, and operational data, which fits the definition of an Interim/Quarterly Report (IR). H1 2022
2022-08-16 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details the share transactions (specifically '장내매수' or on-market purchase) by an executive (Lee Seung-young) of Daehan Pharmaceutical Co., Ltd. This type of filing is a standard regulatory requirement for insider trading/shareholding disclosures, which corresponds to the 'Director's Dealing' category.
2022-08-16 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. It details a specific director's (Lee Seung-young) share acquisition (장내매수) of the company's stock. This falls under the category of 'Director's Dealing' (insider trading/shareholding report).
2022-07-07 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean financial authorities. This type of filing is a standard disclosure for insider trading or changes in share ownership by company directors and executives, which corresponds to the 'Director's Dealing' category.
2022-06-30 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.